Dr. Anthony El-Khoueiry, MD
Claim this profileUSC Norris Comprehensive Cancer Center
Expert in Solid Tumors
Expert in Cancer
35 reported clinical trials
53 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
HER2 positive
Stage III
2Cancer
Global LeaderStage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Anthony El-Khoueiry, MD is currently running
AU409
for Liver Cancer
This trial tests AU409, a new drug, in patients with advanced liver cancers or solid tumors that have spread to the liver. AU409 aims to stop cancer cells from growing and spreading. Researchers are checking if it is safe and effective.
Recruiting1 award Phase 1
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
More about Anthony El-Khoueiry, MD
Clinical Trial Related2 years of experience running clinical trials · Led 35 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Anthony El-Khoueiry, MD has experience with
- Nivolumab
- Pembrolizumab
- Botensilimab
- Durvalumab
- Atezolizumab
- AFM24
Breakdown of trials Anthony El-Khoueiry, MD has run
Solid Tumors
Cancer
Lung Cancer
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anthony El-Khoueiry, MD specialize in?
Anthony El-Khoueiry, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are HER2 positive.
Is Anthony El-Khoueiry, MD currently recruiting for clinical trials?
Yes, Anthony El-Khoueiry, MD is currently recruiting for 10 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Anthony El-Khoueiry, MD has studied deeply?
Yes, Anthony El-Khoueiry, MD has studied treatments such as Nivolumab, Pembrolizumab, Botensilimab.
What is the best way to schedule an appointment with Anthony El-Khoueiry, MD?
Apply for one of the trials that Anthony El-Khoueiry, MD is conducting.
What is the office address of Anthony El-Khoueiry, MD?
The office of Anthony El-Khoueiry, MD is located at: USC Norris Comprehensive Cancer Center, Los Angeles, California 90089 United States. This is the address for their practice at the USC Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.